Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus

Annals of Surgery

Volumn 240, Issue 2, 2004, Pages 286-292

  You, Y Nancy ^a   Tefferi, Ayalew ^a   Nagorney, David M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RELAPSE; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROBABILITY; RECURRENCE; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPLENECTOMY; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 3242674272     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000133182.92780.9c     Document Type: Article

References (38)

1. Gruenberg JC, VanSlyck EJ, Abraham JP. Splenectomy in systemic lupus erythematosus. Am Surg. 1986;52:366-370.
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a five-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Balt). 1999;78:167-175.
3. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age at onset, black race, and thrombocytopenia, as well as cause of death. Arthritis Rheum. 1990;33:37-48.
4. Ward MM, Pyus E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med. 1996;156:1337-1344.
5. Kaplan C, Champeix P. Blanchard D, et al. Platelet antibodies in systemic lupus erythematosus. Br J Haematol. 1987;67:89-93.
6. Pujol M, Ribera A, Vilardell M, et al. High prevalence of platelet autoantibodies in patients with systemic lupus erythematosus. Br J Haematol. 1995;89:137-141.
7. Dixon RH, Rosse WF. Platelet antibody in autoimmune thrombocytopenia. Br J Haematol. 1975;31:129-134.
8. Budman DR, Steinberg AD. Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med. 1977;86:220-229.
9. Lurie DP, Kahaleh MB. Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus. J Rheumatol. 1982;9:311-314.
10. Homan WP, Dineen P. The role of splenectomy in the treatment of thrombocytopenic purpura due to systemic lupus erythematosus. Ann Surg. 1978;187:52-56.
11. Cooper MR, Hansen KS, Maynard CD, et al. Platelet survival and sequestration patterns in thrombocytopenic disorders. Radiology. 1972;102:89-100.
12. West SG, Johnson SC. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med. 1988;108:703-706.
13. Gelfand J, Truong L, Stem L, et al. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kidney Dis. 1985;6:154-160.
14. Sakamoto H, Takaoka T, Usami M, et al. Apheresis: Clinical response to patients unresponsive to conventional therapy. Trans Am Soc Artif Intern Organs. 1985;31:704-710.
15. Vos JJ, van Aken WG, Engelfriet CP, et al. Intravenous gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results with the Netherlands Red Cross immunoglobulin preparation. Vox Sang. 1985;49:92-100.
16. Ahn YS, Harrington WJ, Seelman RC, et al. Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med. 1974;291:376-380.
17. Boumpas DT, Barez S, Klippel JH, et al. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med. 1990;112:674-677.
18. Baldini MG. Idiopathic thrombocytopenic purpura and the ITP syndrome. Med Clin North Am. 1972;56:47-64.
19. Dameshek HL, Ellis LD. Hematologic indications for splenectomy. Surg Clin North Am. 1975;55:253-275.
20. Gadenstatter M, Lamprecht B, Klingler A, et al. Splenectomy versus medical treatment for idiopathic thrombocytopenic purpura. Am J Surg. 2002;184:606-609.
21. Katkhouda N, Hurwitz MG, Rivera RT, et al. Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg. 1998;228:568-578.
22. Hall S, McCormick JL Jr, Greipp PR, et al. Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med. 1985;102:325-328.
23. Coon WW. Splenectomy for cytopenias associated with systemic lupus erythematosus. Am J Surg. 1988;155:391-394.
24. Tan EM, Cohen AS, Fries AF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.
25. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
26. Hakim AJ, Machin SJ, Isenberg DA. Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy. Semin Arthritis Rheum. 1998;28:20-25.
27. Ballerini G, Gemmati D, Moratelli S, et al. Anticardiolipin antibody related thrombocytopenia: Persistent remission after splenectomy. Haematologica. 1995;80:248-251.
28. Galindo M, Khamashta MA, Hughes GR. Splenectomy for the refractory thrombocytopenia in the antiphospholipid syndrome. Rheumatology (Oxford). 1999;38:848-853.
29. Lavalle C, Hurtado R, Quezada JJ, et al. Hemocytopenia as initial manifestation of systemic lupus erythematosus: Prognostic significance. Clin Rheumatol. 1983;2:227-232.
30. Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, et al. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol. 1997;24:867-870.
31. Rivero SJ, Alger M, Alarcon-Segovia D. Splenectomy for hemocytopenia in systemic lupus erythematosus: a controlled appraisal. Arch Intern Med. 1979;139:773-776.
32. Alarcon-Segovia D. Splenectomy has a limited role in the management of lupus with thrombocytopenia. J Rheumatol. 2002;29:1-2.
33. Wagner DS, Schlueter TM. Splenectomy: indications, complications and mortality. Ohio State Med J. 1984;80:610-613.
34. Kumar S, Diehn FE, Gertz MA, et al. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Ann Hematol. 2002;81:312-319.
35. Studenski S, Allen NB, Caldwell DS, et al. Survival in systemic lupus erythematosus: a multivariate analysis of demographic factors. Arthritis Rheum. 1987;30:1326-1332.
36. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 19802: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64.
37. Raguin G, Le Thi Huong D, Piette JC, et al. Splenectomy can cure thrombocytopenia of systemic lupus erythematosus. Presse Med. 1989;18:1739-1742.
38. Amal C, Piette JC, Leione J, et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases. J Rheumatol. 2002;29:75-83.